Food and Drug Administration (FDA) Disclosure:

The statements in this forum have not been evaluated by the Food and Drug Administration and are generated by non-professional writers. Any products described are not intended to diagnose, treat, cure, or prevent any disease.

Website Disclosure:

This forum contains general information about diet, health and nutrition. The information is not advice and is not a substitute for advice from a healthcare professional.

Patent: Cannabis Genomes and Uses Thereof US 20140057251 A1

Discussion in 'Medical Marijuana Usage and Applications' started by jainaG, Oct 11, 2015.

  1. #1 jainaG, Oct 11, 2015
    http://www.google.com/patents/US20140057251
    Publication number
    US20140057251 A1
    Application number
    US 13/588,935
    Publication date
    Feb 27, 2014
    Filing date
    Aug 17, 2012
    Priority date
    Aug 18, 2011
    Inventors
    Kevin McKernan
    Original Assignee
    Medicinal Genomics Corporation
    Export Citation
    BiBTeX, EndNote, RefMan


    Abstract

    Using the efficiency of next generation sequencing, a draft de novo reference sequence for the Cannabis (C.) Sativa and C. Indica genomes
    has been generated as well as four full length contiguous sequences
    with homology to THCA and CBDA synthases and 10 partially homologous
    contigs with truncated ORFs. In particular aspects the invention is
    directed to an (one or more) isolated sequence (e.g., nucleic acid
    sequence, DNA, RNA, genomic sequence, polypeptide) of a Cannabis genome and uses thereof.
     

Share This Page